Daniel SontupeMarket Access
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Liz KaneImpactful Strategy
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
Paul TheisenPatient Acquisition
Matt TurnerPatient Affordability
Stacey GandlerBrand Nourishment
Brenda SnowAuthentic Patient Voice
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Amy GilesIncreasing Engagement
Matthew DurhamOmnidynamic Marketing
Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)[1], ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email